No abstract available
MeSH terms
-
Animals
-
Anti-Inflammatory Agents / therapeutic use
-
Cardiovascular Agents / therapeutic use
-
Diabetes Mellitus, Type 2 / drug therapy
-
Diabetes Mellitus, Type 2 / metabolism
-
Diabetes Mellitus, Type 2 / physiopathology*
-
Diabetic Angiopathies / drug therapy
-
Diabetic Angiopathies / metabolism
-
Diabetic Angiopathies / physiopathology*
-
Endothelium, Vascular / drug effects
-
Endothelium, Vascular / metabolism
-
Endothelium, Vascular / physiopathology*
-
Glycation End Products, Advanced / metabolism*
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Inflammation / drug therapy
-
Inflammation / metabolism
-
Inflammation / physiopathology*
-
Receptor for Advanced Glycation End Products
-
Receptors, Immunologic / metabolism*
-
Signal Transduction*
-
Tumor Necrosis Factor-alpha / metabolism*
Substances
-
Anti-Inflammatory Agents
-
Cardiovascular Agents
-
Glycation End Products, Advanced
-
Hypoglycemic Agents
-
Receptor for Advanced Glycation End Products
-
Receptors, Immunologic
-
Tumor Necrosis Factor-alpha